Cargando…
Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
Malignant mesotheliomas are aggressive, asbestos-related cancers with poor patient prognosis, typically arising in the mesothelial surfaces of tissues in pleural and peritoneal cavity. The relative unspecific symptoms of mesotheliomas, misdiagnoses, and lack of precise targeted therapies call for a...
Autores principales: | Nabavi, Noushin, Bennewith, Kevin L., Churg, Andrew, Wang, Yuzhuo, Collins, Colin C., Mutti, Luciano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302036/ https://www.ncbi.nlm.nih.gov/pubmed/28191281 http://dx.doi.org/10.18632/genesandcancer.124 |
Ejemplares similares
-
Well-Differentiated Papillary Mesothelioma of the Peritoneum Is Genetically Distinct from Malignant Mesothelioma
por: Shrestha, Raunak, et al.
Publicado: (2020) -
Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer Xenografts
por: Nabavi, Noushin, et al.
Publicado: (2018) -
Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma
por: Porta, Camillo, et al.
Publicado: (2008) -
Peritoneal mesothelioma.
por: Churg, J
Publicado: (1974) -
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
por: Shrestha, Raunak, et al.
Publicado: (2019)